CASCADES INC. 2016 Industrial & Construction Conference May - - PowerPoint PPT Presentation

cascades inc
SMART_READER_LITE
LIVE PREVIEW

CASCADES INC. 2016 Industrial & Construction Conference May - - PowerPoint PPT Presentation

CASCADES INC. 2016 Industrial & Construction Conference May 11, 2016 DISCLAIMER Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of


slide-1
SLIDE 1

CASCADES INC.

2016 Industrial & Construction Conference

May 11, 2016

slide-2
SLIDE 2

DISCLAIMER

2

Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of securities legislation based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for Cascades Inc.’s (“Cascades,” “CAS,” the “Company,” the “Corporation,” “us” or “we”) products, the prices and availability of raw materials, changes in the relative values of certain currencies, fluctuations in selling prices and adverse changes in general market and industry conditions. This presentation may also include price indices as well as variance and sensitivity analyses that are intended to provide the reader with a better understanding of the trends related to our business activities. These items are based

  • n the best estimates available to the Company.

The financial information included in this presentation also contains certain data that are not measures of performance under IFRS (“non-IFRS measures”). For example, the Company uses operating income before depreciation and amortization (“OIBD” which, for purposes of this presentation, we call “EBITDA”) and operating income before depreciation and amortization (excluding specific items) (“OIBD (excluding specific items)” which, for purposes of this presentation, we call “EBITDA (excluding specific items)”) because such measures are used by management to assess the operating and financial performance of the Company’s operating segments. Such information is reconciled to the most directly comparable financial measures, as set forth in the “Supplemental Information on Non-IFRS Measures” section of our most recent quarterly report or annual report. Specific items are defined as items such as charges for or reversal of impairment of assets, for facility or machine closures, accelerated depreciation of assets due to restructuring measures, premiums paid on long-term debt refinancing, loss on refinancing of long-term debt, gains or losses on sales of business units, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps, foreign exchange gains

  • r losses on long-term debt, other significant items of an unusual or non-recurring nature, and all such items included in

discontinued operations or in the share of results of our associates and joint ventures. All amounts in this presentation are in Canadian dollars unless otherwise indicated.

slide-3
SLIDE 3

33% 32% 20% 15% Containerboard Tissue Papers Boxboard Europe Specialty Products

Segment Sales Breakdown1

COMPANY OVERVIEW

3

  • Founded in 1964 by the Lemaire family and

headquartered in Kingsey Falls, QC

  • Produces, converts and markets packaging and

tissue products principally composed of recycled fibre

  • Balanced play in less cyclical sectors
  • Heavy exposure to two of the strongest paper

segments: Tissue and Containerboard

  • Market leader across many of its primary

product offerings

  • Unique culture – green visionaries, turnarounds,

entrepreneurial philosophy

  • ~11,000 employees worldwide
1 Before inter-segment sales and corporate activities 2 EBITDA excluding specific items

LTM 3/31/16 Net Sales $3,954 million

47% 27% 13% 13% Containerboard Tissue Papers Boxboard Europe Specialty Products

Segment EBITDA Breakdown1, 2

LTM 3/31/16 EBITDA $447 million

slide-4
SLIDE 4

COMPANY OVERVIEW

Leading Packaging and Tissue Paper Manufacturer

4

Packaging Products

Containerboard

Tissue Papers

Boxboard Europe Specialty Products

Market Position

  • One of the Canadian

leaders

  • # 6 in North America3
  • # 2 in coated recycled

boxboard in Europe

  • Largest paper collector in

Canada

  • # 1 in Canada
  • # 5 in North America

LTM 3/31/16 Financials

  • 33% of Sales1
  • 47% of EBITDA1,2
  • EBITDA Margin2: 18%
  • 20% of Sales1
  • 13% of EBITDA1,2
  • EBITDA Margin2: 7%
  • 15% of Sales1
  • 13% of EBITDA1,2
  • EBITDA Margin2: 10%
  • 32% of Sales1
  • 27% of EBITDA1,2
  • EBITDA Margin2: 11%
1 Before inter-segment sales and corporate activities 2 Excluding specific items 3 Including 100% of Greenpac’s capacity
slide-5
SLIDE 5

5

23% Europe Canada 50% US 27% 23% Europe Canada 37% US 40% 9% Europe Canada 60% US 31% 19% Europe Canada 52% US 29%

Sales from (in %) Sales to (in %) Operating Units (in %) PP&E by Geographic Segment (in %)

Note: Figures as of December 31, 2015

COMPANY OVERVIEW

Sales and Operations Across North America and Europe

slide-6
SLIDE 6

6

GEOGRAPHICALLY DIVERSIFIED

slide-7
SLIDE 7

COMPANY OVERVIEW

Closed-loop Business Model

7

Upstream and downstream integration in North America

80% recycled fibre (2.6M tons) NA integration rate (2015): 28% (0.44M tons) NA integration rate (2015)

  • Containerboard1

64%

  • Tissue Papers

67%

CLIENTS

1 Integration rate for our containerboard activities in North America (considering 100% of Greenpac’s production as internal capacity) 2 Including Reno De Medici’s units and Greenpac. Also including four manufacturing/converting tissue papers units which are counted in both Converting and Manufacturing.

Recovery

  • 19 units

Manufacturing2

  • Containerboard

6 units

  • Boxboard Europe:

6 units

  • Specialty Products:

3 units

  • Tissue Papers:

11 units 26 units

Converting2

  • Containerboard:

18 units

  • Specialty Products:

17 units

  • Tissue Papers:

13 units 48 units

Finished Products

  • Trims and rejects sent to

recycling centers

slide-8
SLIDE 8

1 2 3 4 5 6

Contractual Agreements 23% Regular and Steady Volume (Noncontractual) 27% Recovery & Internal 25% Spot 25%

RAW MATERIALS

Reliable Sourcing Strategy

8

20151

Most of the fibre supply coming from internal sources, contracts and regular streams

Top Recovered Paper Suppliers in the World Cascades’ North American Recycled Fibre Supply Our Strategy

  • Constant review of our inventory strategy
  • Ensure control over fibre supply with potential to

increase tons under control

  • Develop substitute grades

(M Tonnes)

Source: RISI

  • Continue to increase integration rate with CAS’ other

segments

  • Potential to increase virgin content in certain

circumstances

  • Continue to close the loop with customers & retailers
1 Including volume treated for Greenpac
slide-9
SLIDE 9

285 342 340 426 447 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% 18.0% 200 250 300 350 400 450 500 2012 2013 2014 2015 LTM 3/31/16 3,141 3,370 3,561 3,861 3,954 2,750 3,000 3,250 3,500 3,750 4,000 4,250 2012 2013 2014 2015 LTM 3/31/16

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Strong Financial Momentum

9

Sales EBITDA (excl. specific items)

(M CAN$) (M CAN$)

Improved results reflect improved productivity, FX and stable raw material & energy costs

slide-10
SLIDE 10

138 133 96 119 138 0% 20% 40% 60% 80% 100% 25 50 75 100 125 150 2012 2013 2014 2015 LTM 3/31/16 37 41 40 58 62 0% 20% 40% 60% 80% 100% 20 40 60 80 100 2012 2013 2014 2015 LTM 3/31/16 43 57 72 63 62 0% 20% 40% 60% 80% 100% 20 40 60 80 100 2012 2013 2014 2015 LTM 3/31/16 90 150 164 231 234 0% 20% 40% 60% 80% 100% 50 100 150 200 250 300 2012 2013 2014 2015 LTM 3/31/16

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Historical Segmented EBITDA

10

Containerboard Boxboard Europe Specialty Products Tissue Papers

(M CAN$) (M CAN$)

Green line represents segment EBITDA as percent of total Company EBITDA; EBITDA excluding specific items

(M CAN$) (M CAN$)

slide-11
SLIDE 11

(0.28) 0.78 0.86 1.58 1.60 (0.50) 0.00 0.50 1.00 1.50 2.00 2012 2013 2014 2015 LTM 3/31/16 155 233 277 337 358 100 200 300 400 2012 2013 2014 2015 LTM 3/31/16

1 Excluding specific items 2 Excluding increase in investments

11

Objective of ~$100M of free cash flow annually directed toward debt reduction

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Cash Flow and Free Cash Flow per Share

Free Cash Flow per Share1,2 Cash Flow From Operating Activities1

  • Cash flows have grown at a 29% CAGR

since 2012

  • Improving cash flows driven by Strategic

Action Plan

(M CAN$) (CAN$)

slide-12
SLIDE 12

184 161 184 173 185 100 150 200 2012 2013 2014 2015 2016B

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Capital Expenditures

12

Capital Expenditures

  • Divestitures and free cash flow have

funded capital expenditures

(M CAN$)

  • 2016 level to be slightly higher at ~$185M,

including IT

  • Mainly growth Capex
  • Mostly towards US

Capex Distribution for FY2015 – $173M

Specialty Products Containerboard 37% Tissue Papers 33% 13% 8% 9% Corporate Boxboard Europe

slide-13
SLIDE 13

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Debt Maturities

13

Refinancings in 2014 and 2015 resulting in +US$20 million interest savings

  • Over last 24 months, $1 billion+ of

senior notes refinanced

  • Extended maturities to 2021,

2022 and 2023

  • $750 million revolving facility

extended to 2019

  • Average interest rate down 112 bps

to 4.93% in 2015 from 6.05% in 2013

  • Resulted in interest savings of

~$23 million annually

33 132 282 250 714 325 250 500 750 1,000 1 year > 1 year 2019 2021 2022 2023 Debts without recourse Subsidiaries debts Revolver Senior notes

Debt Repayment as at March 31, 2016

slide-14
SLIDE 14

14

BUSINESS SEGMENT HIGHLIGHTS

Attractive Containerboard Market Conditions with Greenpac Investment Delivering Results Strong Position Across the North American Tissue Market Boxboard Europe Continues to Strengthen with Recent Rationalizations and Asset Improvements Specialty Products Group Provides a Stable Source of Revenue, Unique Platform for Innovation and Hedge for Recovered Paper Price Volatility

slide-15
SLIDE 15

60% 70% 80% 90% 100% Q1 2009 Q1 2010 Q1 2011 Q1 2012 Q1 2013 Q1 2014 Q1 2015 Q1 2016

North American Containerboard Producers

40.0 36.0 38.0 42.0 44.0 1.0

2014

39.9 0.7

New capacity

0.9 42.2

New capacity 2018e

43.1

New capacity 2017e

0.6 40.9

New capacity 2016e

41.5

2015e

CONTAINERBOARD

Environment Still Sound

15

Fundamentals Sound Despite Added Capacity

Operating Rates and Expected Capacity

(Million s.t.)

% of total capacity

IP 33%

WestRock 19%

GP 10%

PCA 10%

Kapstone 4%

Cascades 4%

Pratt 4% Others 16% Top-5 Producers 76% 2015 Industry Participants

Source: RISI, Deutsche Bank, Company reports and estimates

1 Including 59.7% of Greenpac’s total capacity

2 SP Fiber PCA D3 Yr 2 Pratt Yr 1 Greif Yr 1 IP Valliant Yr 1

  • Corr. Supplies

Productivity 1% Pratt Yr 2 Greif Yr 2 IP Valliant Yr 2 SP Fiber Yr 2

  • Corr. Supplies

Productivity 1%

1

(Operating rate)

Kruger Yr 1

  • Corr. Sup. Yr 1

Productivity 1% Kruger Yr 1

  • Corr. Sup. Yr 1

Productivity 1%

(+2.5%) (+1.5%) (+1.7%) (+2.1%)

slide-16
SLIDE 16

CONTAINERBOARD

Our Strategic Move: Greenpac

16

Note: Greenpac is not consolidated in the results and balance sheet since Cascades does not have effective control under IFRS

  • Largest recycled linerboard mill in NA:

1,500 s.t./day of lightweight recycled linerboard (26 pounds)

  • State-of-the-art equipment
  • Product differentiation:

Greenpac XP grades represent 75% of total production in Q1-2016

  • Take-or-pay agreement for 81%
  • f the mill’s output
  • 59.7% ownership:
  • Partners include a pension

fund and two independent converters

slide-17
SLIDE 17

6% 7% 9% 8% 7% 33 40 48 45 43 10 20 30 40 50 2012 2013 2014 2015 LTM Q1-2016 (M€)

BOXBOARD EUROPE

Stronger and Leaner Production Platform

17

  • ~58% ownership of RdM, a public Italian company, and 100% of a virgin board mill in France
  • Rationalization of production capacity, consolidation of sales forces, structure simplification and

modernization investments have resulted in improved performance

M

Manufacturing – Recycled grades Manufacturing – Virgin grades

M M MM M M M

#2 Producer of Coated Recycled Boxboard in Europe EBITDA & EBITDA Margin

Energy credits totaling €4M in 2013, €6M in 2014

slide-18
SLIDE 18

SPECIALTY PRODUCTS GROUP

Stable Source of Revenue and Unique Platform for Innovation

18

  • Largest recycled paper collector in

Canada

  • 19 units
  • Largest producer of honeycomb in

Canada

  • 6 units
  • Leading producer of papermill packaging
  • 12 units
  • JV Share of EBITDA $10-$15M
  • Diversified product offerings and stable revenue stream with leading market positions
  • Recent initiatives have included
  • Cascades Recovery minority (27%) acquisition completed in December 2015
  • Restructuring and minority acquisition of Norcan

Recycling and Recovery (~30% of sales1) Consumer Packaging Products (~20% of sales1) Industrial Packaging Products (~45% of sales1)

  • 2 units
  • Vinyl backing
  • Deinked pulp

Other Products (~5% of sales1)

1 Including 100% of joint ventures
slide-19
SLIDE 19

9,230 9,390 9,570 9,818 10,382 160 180 248 564 2,500 5,000 7,500 10,000 12,500 2009 New capacity 2011 New capacity 2013 New capacity 2015 New capacity 2017e

Branded 56% Private Label 44% At-Home 44% Away-from- Home 39% Parent Rolls 17% Branded 11% Private Label 89%

TISSUE PAPERS

Stong Position Across the North American Tissue Market

19

Source: RISI

Sales by Geography (2015) Sales by End Markets (2015) Tissue Market Demand North American Tissue Capacity Additions

80 100 120 140 160 1996 2000 2004 2008 2012 2016E Indexed U.S. Tissue Demand (M s.t.)

At-Home 58% At-Home 51% Away-from- Home 42% Away-from- Home 49%

Canada (25%) US (75%)

(+1.7%) (+1.9%) (+2.6%) (+5.7%)

slide-20
SLIDE 20

TISSUE PAPERS

Extended Geographical Reach

20

2015 NORTH AMERICAN TISSUE MANUFACTURERS Capacity ('000 s.t.) Market Share Capacity Retail Capacity AfH 1 Georgia-Pacific 2,849 29% 67% 33% 2 Procter & Gamble 1,494 15% 100% 0% 3 Kimberly-Clark 1,466 15% 67% 33% 4 SCA Tissue NA 772 8% 0% 100% 5 Cascades Tissue 657 7% 62% 38% 6 Clearwater Paper 435 4% 90% 10% 7 KP Tissue 399 4% 77% 23% 8 First Quality Tissue 290 3% 100% 0% 9 Irving Tissue 282 3% 100% 0% 10 Soundview Paper 161 2% 67% 33% Others 1,012 10% TOTAL 9,818 100%

Source: RISI, Company reports and estimates

slide-21
SLIDE 21

POTENTIAL BENEFITS STEMMING FROM OUR INITIATIVES

21

Other sources of growth and incremental value

  • Culture of innovation
  • Good performance from European platform and hidden value of Boralex investment
  • On-going initiatives to improve our business processes

Modernizing our operating platform to increase profitability

  • $185M capex program in 2016
  • Divestitures and closures of under-performing units
  • Containerboard: sound fundamentals and improved platform
  • Modernized converting platform and manufacturing productivity improvement
  • Greenpac to positively contribute to EPS for a second full year in 2016
  • Tissue Papers: strong and growing position in North America
  • Increasing presence in the US with recent expansion initiatives

Potential tailwinds

  • CAD$ weakness
  • More stable economic reality in Canada, the US and Europe
  • China’s economic weakness and favourable impact on recovered paper prices
  • Lower oil and gas costs

  

Taking the right steps to position Cascades for the future

slide-22
SLIDE 22

22

For more information:

www.cascades.com/investors Jennifer Aitken, MBA Director, Investor Relations 514-282-2697 or investor@cascades.com